U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Hemispherx Biopharma, Inc. (HEB)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.340.00 (0.00%)
At close: 3:59PM EDT
People also watch
GNBTCVMCTICBCRXVICL
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue92133197
Cost of Revenue1,1081,5981,251
Gross Profit-1,016-1,465-1,054
Operating Expenses
Research Development5,1078,0388,988
Selling General and Administrative7,6817,1479,057
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-13,804-16,650-19,099
Income from Continuing Operations
Total Other Income/Expenses Net6,3021,4231,660
Earnings Before Interest and Taxes-7,502-15,227-17,439
Interest Expense-311
Income Before Tax-7,502-15,230-17,450
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,502-15,230-17,450
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,502-15,230-17,450
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,502-15,230-17,450